Loading...
XSHG
603983
, Last price  
CNY
Name

Guangdong Marubi Biotechnology Co Ltd

Chart & performance

D1W1MN
XSHG:603983 chart
P/E
—
P/S
—
EPS
0.62
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
14.67%
Div Yld LY
—
Div Yld TTM
—
Revenues
3.46b
+16.48%
613,183,700814,914,500973,736,6001,075,512,7101,191,230,2351,208,125,2011,352,323,3841,575,763,9551,800,857,5891,744,989,0591,787,028,5631,731,716,4572,225,594,0892,969,770,5663,459,318,084
Net income
247m
-27.63%
167,258,100186,877,300218,614,800271,374,198281,434,575232,189,704311,919,392415,278,456514,887,921464,399,184247,921,315174,183,373259,417,875341,628,712247,239,140
CFO
274m
-8.87%
269,389,965227,490,853325,667,600376,235,500275,113,400213,332,612356,202,160516,693,624465,531,842362,345,691048,435,682338,022,493300,526,858273,876,402
Dividend
Jul 15, 20260.25 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 2002 and headquartered in Guangzhou, China, Guangdong Marubi Biotechnology Co., Ltd. specializes in a range of cosmetic products. While a key focus lies in providing eye care solutions across China, the company's activities span the entire process from scientific research and development, through design and production, to the ultimate sale of its beauty offerings. These products are formulated drawing upon expertise in both skin and biological sciences. Consumers can find their goods marketed under the brand names Marumi, Chunji, and Lianhuo.

Key people

Huaiqing Sun
Chairman of the Board, President, Founder
IPO date
Jul 25, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT